Several clinical trials are ongoing to assess the safety and efficacy of CAR‐T cells using different GBM‐associated antigens such as EGFRvIII, NKG2D, B7‐H3, CD147, IL13Ralpha2, and HER2. The gene discussed is BSG; the disease is glioblastoma.